• Centellase 30 mg 30 tablets
1 1

Sit Laboratorio Farmaceutico

Centellase 30 mg 30 tablets

Centellase 30 mg 30 tablets

€15,35
€16,50 €15,35
Sale Sold out
Taxes included. Shipping calculated at checkout.
Logo Farmaci da banco

NET WEIGHT OF THE PRODUCT

30ct

EAN

016222073

MINSAN

016222073

View full details

In ottemperanza all'articolo 118 “autorizzazione della pubblicità presso il pubblico” del decreto legislativo 24 aprile 2006, numero 219

INDICATIONS

Symptoms attributable to venous insufficiency; states of capillary fragility.

 

ACTIVE INGREDIENTS

1 tablet contains: total triterpene fraction of gotu kola (asiaticoside 40% – asiatic acid + madecassic acid 60%) 30 mg. For the full list of excipients, see section 6.1.

 

EXCIPIENTS

Dibasic calcium phosphate dihydrate, sodium docusate, povidone, sodium croscarmellose, sodium carmellose, magnesium stearate.

 

CONTRAINDICATIONS AND SIDE EFFECTS

Hypersensitivity to the active substance or to any of the excipients listed in paragraph 6.1.

 

DOSAGE

Dosage 1 to 2 tablets per day, preferably at meal times. The medicine should only be used for a short period of treatment. Method of administration: oral use.

 

CONSERVATION

This medicinal product does not require any special storage conditions.

 

WARNINGS

No particular precautions for use of the product.

 

INTERACTIONS

There are no known interactions with other drugs.

 

SIDE EFFECTS

Cases of itching and photosensitivity reactions with the appearance of redness and skin rashes have been reported after oral administration of the drug. Reporting of suspected adverse reactions Reporting suspected adverse reactions that occur after authorization of the medicine is important, as it allows continuous monitoring of the benefit/risk balance of the medicine. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at: http://www.agenziafarmaco.gov.it/it/responsabili.

 

OVERDOSE

No cases of overdose have been reported.

 

PREGNANCY AND BREASTFEEDING

Studies conducted on animals have not shown reproductive toxicity. There are no adequate data from the use of the drug in pregnant women or during breastfeeding. Centellase should not be used during pregnancy and breastfeeding.

 

EFFECTS ON DRIVING ABILITY

Centellase does not affect the ability to drive or use machines.

OUR PRODUCTS FOR THIS SEASON

1 10
View all
1 4

Content Responsibility This sheet contains information that is not intended to replace a diagnosis or medical advice, as only the doctor can draw up any prescription and give therapeutic indications. All contents must be understood and are of an exclusively informative nature and aimed exclusively at bringing to the attention of customers or potential customers in the pre-purchase phase of the products sold through this site. In case of pathologies, disorders or allergies it is always best to consult your doctor first. Please note The names of the products, the ingredients and the percentages indicated in the descriptions are purely indicative, they may be subject to changes or updates by the manufacturing companies. Due to the impossibility of adapting in real time to such updates, the photos and technical information of the products inserted on Dottortili.com may differ from those reported on the label or otherwise disseminated by the manufacturing companies. The only identification element is the MINSAN ministerial code. The online pharmacy Dottortili.com does not guarantee the truthfulness and timeliness of the information published and declines all responsibility for any errors, omissions or failure to update the same. Dottortili.com does not assume responsibility for damages of any nature that may arise from access to the information published. Data source: Farmadati Italia Website: www.farmadati.it The Farmadati Italia Database is used by almost all pharmacies, parapharmacies, herbalist shops, health shops, large-scale retail trade, computerized doctors, etc. thanks to the company's historical guarantee of reliability, seriousness and professionalism on the national territory. The Farmadati Italia Srl management system complies with the requirements of the UNI EN ISO 9001:2015 standards for quality management systems and UNI CEI ISO/IEC 27001:2017 for information security management systems.